EVO ICL™

Are you looking for a reversible and refractive solution for your patients with low and high ametropia and incipient presbyopia? Would you like to expand your refractive offering for Femto-LASIK and Trans-PRK and provide your patients with all the options?

*Please note that this materials are intended for medical education. By proceeding, you certify that you are a licensed health care professional.*

The EVO ICL is a phakic intraocular and reversible implant.

EVO is a clinically proven implantable lans that corrects common vision problems such as nearsightedness with or without astigmatism.
It is placed directly behind the iris and in front of the natural crystalline lens. The addition of the central port to EVO facilitates the flow of aqueous humor through the lens.
The EVO ICL procedure does not require the removal of any corneal tissue. Its material Collamer is a poly-HEMA-based copolymer with a UV absorbing chromophore that provides UV protection.

EVO ICL Implantation at a glance

 

-  3 000 000+ LENSES SOLD GLOBALLY

-  30 YEARS OF EXPERIENCE

-  +500 SCIENTIFIC PUBLICATIONS

-  +1 000 PEER-REVIEWED PUBLICATIONS

 

EVO HCP Brochure

Collamer

Collamer™ has a proven history of over 30 years and is the one-of-a-kind material that defines EVO ICL™ worldwide it is a proprietary co-polymer behind the EVO ICL lens it is a biocompatible meterial with properties that minimize inflammation, flare and cellular reaction.

 

Patient Selection

The EVO ICL family of lenses is indicated for use in phakic eye treatment in patients 21 - 60 years of age who meet the criteria listed below:
- The correction/reduction of myopia with or without astigmatism
- Requiring a lens with sphere power of -0.5 D to -18.0 D and cylinder pawer up to +6.0 D
- With an anterior chamber depth (ACD) equal to or greater than 2.8 mm, as measured from the corneal endothelium to the anterior lens capsule

 

Patient Selection Guide

Certification course

To ensure you are able to implement the lens successfully, you will go through a certification course with our ICL specialists. This course provides you with the necessary knowledge about the EVO ICL, patient selection, preliminary examinations, lens determination and intraoperative handling with OP support. We would be happy to train the team at your practice and support you in marketing. After completing the proctoring, you can save your contact profile on ICL Discovery; you will also be an accredited EVO ICL operator.

Contact us

Important Safety Information for the EVO/EVO+ ICL
All physicians must complete the STAAR Surgical Visian ICL Physician Training Certification Program prior to using the EVO/EVO+ ICL in a clinical setting. Please review the EVO/EVO+ ICL Directions For Use (DFU) completely before performing a clinical procedure. 
INDICATIONS: The EVO/EVO+ ICL is indicated for phakic patients 21-60 years and pseudophakic patients 21 years and older with an anterior chamber depth (ACD) 2.8 mm or greater to correct/reduce myopia ranging from -0.5 diopters to -20.0 diopters with up to 6.0 D of astigmatism. The EVO/EVO+ ICL is intended for placement in the posterior chamber of the eye. WARNING/PRECAUTION: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/ benefit ratio before implanting a lens in a patient with any of the conditions described in the DFU. Prior to surgery, physicians should inform prospective patients of possible risks and benefits associated with the EVO/EVO+ ICL. ATTENTION: Reference the EVO/EVO+ ICL DFU available at edfu.staar.com/edfu/ for a complete listing of indications, contraindications, warnings and precautions.